Why I’d shun falling knife Carillion plc for this ‘secret’ growth stock

Carillion plc (LON: CLLN) may take your fingers but this surprise growth stock could give power to your elbow, says Harvey Jones.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Catching a falling knife is always dangerous, just ask any investor who snatched at Carillion (LSE: CLLN) in recent months. They were already hurting, even before Friday’s vicious scythe downwards, which saw the stricken support services company’s share price drop as much as 50% at one point.

Profit crash

The wipeout put the tin lid on a dreadful 2017 for the group, whose share price has fallen 90% in the past 12 months (and the year isn’t over yet). Management’s hard work cutting costs and raising cash has come to little with balance-sheet debt now many times its fast-shrinking market capitalisation.

On Friday management issued yet another profit warning, revealed higher than expected net debt, warned it will breach banking covenants by the end of the year, and announced a recapitalisation. It was dreadful, and the problems will not even begin to be properly tackled until next year.

The dreaded shrinks

Thankfully, I have been urging caution to knife catchers. On 26 July I warned Stand clear: Carillion plc has further to fall! The crash threw up serious underlying problems that would look even worse when exposed to the light day, and any turnaround would take a long time. “It’ll have your fingers if you let it”, I wrote. I hope it didn’t.

Carillion’s new, reduced market cap of just £111m will make recapitalisation even harder (it was £180m on Thursday). Do not be tempted by the rock bottom valuation of just 1.5 times earnings, the road to respectability will be a long one. Traders might want to play it, investors should steer clear.

Power up

Company share prices can fall for a long time, just look at FTSE 250 power generation specialist Aggreko (LSE: AGK). Its share price peaked at 2,400p in 2012 and sank as low as 850p in August 2017. The group was hit by the oil and gas industry downturn as well as the slowing economy in Latin America, but in recent months it has started a comeback.

In August I said there is light at the end of the tunnel as CEO Chris Weston reported good progress in boosting the group’s product offering and reducing its cost base, with £100m of cash savings targeted. The share price has climbed around 12% since then to 955p. In contrast to Carillion the bad news has mostly been flushed out, and the comeback appears to be under way.

Right place

Lest we get carried away, earnings per share are forecast to fall 9% in 2017, the fifth consecutive annual drop, but City analysts foresee brighter times with a 13% climb in 2018. I wish Aggreko was a bit cheaper, it currently trades at a forward valuation of 16.9 times earnings. The dividend yield of 2.9% is solid if not spectacular, but at least it is covered two times.

The market is waking up to Aggreko’s recovery potential with Jefferies claiming this week that everything is falling into place and the stock is now a buy. The broker has doubled its target price from 850p to 1,250p, which would suggest 30% upside from here. Aggreko has the power, Carillion does not.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »